Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation

NCT00281554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: RSD1235

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]